Trials / Sponsors / Devalingam Mahalingam
Devalingam Mahalingam
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | 2022-09-13 |
| No Longer Available | Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | — | — |